Chief Clinical Officer and founding partner Mark Adams, DDS, and Director of Clinical Research & Development Steven Eckert, DDS, will retire at the end of 2022, according to a Dec. 13 news release from ClearChoice.
Following their retirement, Dr. Adams and Dr. Eckert will be succeeded by Theresa Wang, DDS, and Hans-Peter Weber, DMD, respectively.
ClearChoice is supported by the Aspen Group. The network has more than 80 centers nationwide.